📖

RNA Editing Therapeutics

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-technologies-rna-editing-therapeuti
Related Entities
technologies-rna-editing-therapeutics
Metadata
slugtechnologies-rna-editing-therapeutics
entity_typetechnology
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (525)
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🔬RNA binding protein dysregulation across ALS FTD AD75%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD75%
mentions🧫Microarray and single-cell RNA analysis of lipid metabolism 70%
mentions🧫dilncRNA-mediated molecular crowding and phase separation70%
mentions🧫Competing endogenous RNA (ceRNA) network construction70%
mentions🧫Factor depletion effects on DDR focus formation in vivo70%
mentions🧫Activity-dependent PGC-1α transcriptional program analysis70%
mentions🧫scRNA-seq analysis of human atherosclerotic plaques70%
mentions🧫Multi-omics analysis of NP137 mechanism in patient biopsies70%
mentions🧫Sevoflurane-induced neurotoxicity (SIN) model in rats70%
mentions🧫PGC-1α expression analysis during PV+ interneuron developmen70%
mentions🧫Multi-omics analysis of myricanol effects on gene expression70%
mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha70%
mentions🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m70%
mentions🧫LINC00599-MYH9 liquid-liquid phase separation analysis70%
mentions🧫Single-cell RNA sequencing analysis of human atherosclerotic70%
mentions🧫NPM1 knockout tumor progression study in syngeneic mice70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫dilncRNA-mediated molecular crowding and phase separation70%
mentions🧫Single-cell RNA-seq analysis of mouse testes with gonadal de70%
mentions🧫Gestational haloperidol exposure effects on hippocampal gene70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫Machine learning-based identification of C1Q hub genes70%
mentions🧫Single-cell RNA sequencing of microglial states in AD hippoc70%
mentions🧫Single-cell RNA sequencing of EMT states in SCC70%
mentions🧫BDEV injection and recipient microglial transcriptome analys70%
mentions🧫Sevoflurane-induced neurotoxicity (SIN) rat model70%
mentions🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter70%
mentions🧫Single-cell RNA sequencing analysis of microglial heterogene70%
mentions🧫Single-nucleus RNA-seq integration analysis70%
mentions🧫Small RNA profiling of neonatal astrocyte EVs and microglia 70%
mentions🧫ZNF263-mediated LINC00599 transcriptional regulation70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫s:** - Compare uptake with/without magnetic particles using 70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫Proposed experiment from debate on Perivascular spaces and g70%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫s:** - Dose-response studies showing therapeutic window with70%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫FLS Stimulation and Transcriptomic Analysis70%
mentions🧫Single-cell RNA sequencing of mouse brains70%
mentions🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro70%
mentions🧫LINC00599 role in human PASMC proliferation70%
mentions🧫LINC00599 expression analysis in hypoxic PH models70%
mentions🧫DDR factor depletion and focus formation analysis70%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%
mentions🧫AAV-LRRK2 IND-Enabling Study Design70%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?70%
mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫ApoE4 Function in Alzheimer's Disease70%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 70%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%
mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%
mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa70%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%
mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen70%
mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%
mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%
mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Microglial Contributions to Huntington's Disease Pathog70%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%
mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
mentions🧫Parkinson's Disease Subtype Classification — Precision 70%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel70%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%
mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%
mentions🧫Experiment Validation: In vitro ThT Assay70%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
mentions🧫Tau ASO Therapy70%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy70%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🔬RNA binding protein dysregulation across ALS FTD AD67%
related🔬RNA binding protein dysregulation across ALS FTD and AD67%
related🧫Microarray and single-cell RNA analysis of lipid metabolism 63%
related🧫dilncRNA-mediated molecular crowding and phase separation63%
related🧫Competing endogenous RNA (ceRNA) network construction63%
related🧫Factor depletion effects on DDR focus formation in vivo63%
related🧫Activity-dependent PGC-1α transcriptional program analysis63%
related🧫scRNA-seq analysis of human atherosclerotic plaques63%
related🧫Multi-omics analysis of NP137 mechanism in patient biopsies63%
related🧫Sevoflurane-induced neurotoxicity (SIN) model in rats63%
related🧫PGC-1α expression analysis during PV+ interneuron developmen63%
related🧫Multi-omics analysis of myricanol effects on gene expression63%
related🧫G3BP1-mediated stress granule assembly via liquid-liquid pha63%
related🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m63%
related🧫LINC00599-MYH9 liquid-liquid phase separation analysis63%
related🧫Single-cell RNA sequencing analysis of human atherosclerotic63%
related🧫NPM1 knockout tumor progression study in syngeneic mice63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫dilncRNA-mediated molecular crowding and phase separation63%
related🧫Single-cell RNA-seq analysis of mouse testes with gonadal de63%
related🧫Gestational haloperidol exposure effects on hippocampal gene63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫Machine learning-based identification of C1Q hub genes63%
related🧫Single-cell RNA sequencing of microglial states in AD hippoc63%
related🧫Single-cell RNA sequencing of EMT states in SCC63%
related🧫BDEV injection and recipient microglial transcriptome analys63%
related🧫Sevoflurane-induced neurotoxicity (SIN) rat model63%
related🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter63%
related🧫Single-cell RNA sequencing analysis of microglial heterogene63%
related🧫Single-nucleus RNA-seq integration analysis63%
related🧫Small RNA profiling of neonatal astrocyte EVs and microglia 63%
related🧫ZNF263-mediated LINC00599 transcriptional regulation63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I63%
related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫s:** - Temporal analysis showing mitochondrial defects prece63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫s:** - Compare uptake with/without magnetic particles using 63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫Proposed experiment from debate on Perivascular spaces and g63%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫s:** - Dose-response studies showing therapeutic window with63%
related🧫Proposed experiment from debate on Senolytics targeting p16/63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫FLS Stimulation and Transcriptomic Analysis63%
related🧫Single-cell RNA sequencing of mouse brains63%
related🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro63%
related🧫LINC00599 role in human PASMC proliferation63%
related🧫LINC00599 expression analysis in hypoxic PH models63%
related🧫DDR factor depletion and focus formation analysis63%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera63%
related🧫AAV-LRRK2 IND-Enabling Study Design63%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau63%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio63%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model63%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?63%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫ApoE4 Function in Alzheimer's Disease63%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration63%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 63%
related🧫Blood-Based Biomarker Panel for Early AD Detection63%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka63%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%
related🧫CRISPR Gene Correction Approaches for CBS/PSP63%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa63%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 63%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen63%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise63%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa63%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P63%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Microglial Contributions to Huntington's Disease Pathog63%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#63%
related🧫Parkinson's Disease Subtype Classification — Precision 63%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic63%
related🧫Progranulin Replacement Therapy for FTD — Vector Development63%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD63%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise63%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel63%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec63%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D63%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di63%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki63%
related🧫TDP-43 PET Ligand Development for FTD and ALS63%
related🧫Experiment Validation: In vitro ThT Assay63%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%
related🧫Tau ASO Therapy63%
related🧫Microglial TREM2 Agonist In Vivo Efficacy63%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia63%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 63%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
see_also📖Neuroinflammation PET Imaging in CBS/PSP60%
see_also📖entities-bace160%
see_also📖entities-gfap60%
see_also📖entities-tfeb60%
see_also📖entities-tlr460%
see_also📖TREM2 Protein (Triggering Receptor Expressed on Myeloid Cell60%
see_also📖BDNF Gene60%
see_also📖C3 — Complement Component 360%
see_also📖NURR1 Gene60%
see_also📖PPARGC1A Gene60%
see_also📖SIRT6 Gene60%
see_also📖hypotheses-apoe-contributes-alzheimers-disease-regulat60%
see_also📖NLRP3 Inflammasome Hypothesis in Parkinson's Disease60%
see_also📖CX3CR1 Modulation Therapy for Neurodegeneration60%
see_also📖VCP Proteostasis Modulation Therapy for ALS/FTD60%
related🔬What are the mechanisms underlying rna binding protein dysre54%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Microbial Inflammasome Priming Prevention50%
mentions🧪Digital Twin-Guided Metabolic Reprogramming50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%
mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%
mentions🧫Cytochrome Therapeutics50%
mentions🧪Smartphone-Detected Motor Variability Correction50%
mentions🧪Purinergic Signaling Polarization Control50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪Ganglioside Rebalancing Therapy50%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%
mentions🧪Mitochondrial RNA Granule Rescue Pathway50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%
mentions🧪Retinal Vascular Microcirculation Rescue50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪Glycosaminoglycan Template Disruption Approach50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
mentions🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪Extracellular Matrix Stiffness Modulation50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%
mentions🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR50%
mentions🧪Membrane Cholesterol Gradient Modulators50%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%
mentions🧪Flotillin-1 Stabilization Compounds50%
mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration50%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Microglia-Derived Extracellular Vesicle Engineering for Targ50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪Nucleolar Stress Response Normalization50%
mentions🧪Cross-Seeding Prevention Strategy50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%
mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and44%
mentions🧫tACS Connectivity Trial in Early Alzheimer's44%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design44%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro44%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model44%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring44%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model44%
mentions🧫Leukocyte gene expression analysis in COVID-19 patients44%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS44%
mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#44%
mentions🧫Functional validation of trehalose effects on misfolded prot44%
mentions🧫Trehalose-induced lysosomal changes and TFEB activation44%
mentions🧫Trehalose-induced lysosomal membrane permeabilization and TF44%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪Smartphone-Detected Motor Variability Correction40%
related🧪Purinergic Signaling Polarization Control40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪Ganglioside Rebalancing Therapy40%
related🧪Mitochondrial SPM Synthesis Platform Engineering40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪SASP-Mediated Cholinergic Synapse Disruption40%
related🧪Mitochondrial RNA Granule Rescue Pathway40%
related🧪Multi-Modal Stress Response Harmonization40%
related🧪Complement C1q Mimetic Decoy Therapy40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Retinal Vascular Microcirculation Rescue40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪SASP-Mediated Complement Cascade Amplification40%
related🧪Complement C1q Subtype Switching40%
related🧪Autophagosome Maturation Checkpoint Control40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪Prefrontal sensory gating circuit restoration via PV interne40%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%
related🧪PARP1 Inhibition Therapy40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪Perforant Path Presynaptic Terminal Protection Strategy40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🧪Lipid Droplet Dynamics as Phenotype Switches40%
related🧪Circadian-Synchronized LRP1 Pathway Activation40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
related🧪Stress Granule Phase Separation Modulators40%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%
related🧪Pharmacological Enhancement of APOE4 Glycosylation40%
related🧪Membrane Cholesterol Gradient Modulators40%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Lysosomal Enzyme Trafficking Correction40%
related🧪Circadian Clock-Autophagy Synchronization40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Ephrin-B2/EphB4 Axis Manipulation40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Nucleolar Stress Response Normalization40%
related🧪Cross-Seeding Prevention Strategy40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%
mentions🔬What are the mechanisms underlying apoe4 structural biology 35%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying protein aggregation cross35%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 35%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli35%
mentions🔬What are the mechanisms underlying sleep disruption as cause35%
mentions🔬What are the mechanisms underlying synaptic pruning by micro35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%
mentions🔬What are the mechanisms underlying perivascular spaces and g35%
mentions🔬Analyze circuit-level changes in neurodegeneration using All35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%